| Medius AG - Betoptic-S, Augentropfensuspension | | 51760 | | 01 | | Betoptic-S | | Augentropfensuspension | | S01ED02 | | Betaxolol | | 07.06.1995 | | |
| | Composition | | betaxololum 2.5 mg ut betaxololi hydrochloridum, natrii polystyrensulfonas, carbomerum 974P, dinatrii edetas, benzalkonii chloridum 100 µg, mannitolum, natrii hydroxidum aut acidum hydrochloridum ad pH, acidum boricum, lauroyl sarcosine, aqua purificata ad suspensionem pro 1 ml. | | Packungsbestandteile | | Collyre | | | | | | | | Principe actif | Concentr. |
|---|
| Betaxolol | 2.5 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Betaxolol | 2.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Borique | | | Benzalkonium Chlorure | 100 µg/ml | | Carbomerum 974P | | | Dinatrii Edetas | | | Lauroyl Sarcosine | | | Mannitol | | | Natrii Hydroxidum aut Acidum Hydrochloridum ad Ph | | | Sodium Polystyrensulfonate | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 018 | 5 ml | 5.05 | 14.75 | B | LS | Oui | | 026 | 3 x 5 ml | 12.89 | 30.45 | B | LS | Oui |
|
|
